Seroatlas · Human Serome Atlas

RPL35A

Large ribosomal subunit protein eL33

Also known as: eL33, GIG33, L35A, RL35A_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P18077
Gene
RPL35A
Ensembl
ENSG00000182899
Chromosome
3
Canonical length
110 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins, Ribosomal proteins

OverviewNCBI Gene

Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L35AE family of ribosomal proteins. It is located in the cytoplasm. The rat protein has been shown to bind to both initiator and elongator tRNAs, and thus, it is located at the P site, or P and A sites, of the ribosome. Although this gene was originally mapped to chromosome 18, it has been established that it is located at 3q29-qter. Alternative splicing results in multiple transcript variants. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Oct 2015]

Canonical amino-acid sequenceUniProt

110 residues, UniProt reviewed canonical sequence.

>P18077|RPL35A
     1  MSGRLWSKAI FAGYKRGLRN QREHTALLKI EGVYARDETE FYLGKRCAYV YKAKNNTVTP
    61  GGKPNKTRVI WGKVTRAHGN SGMVRAKFRS NLPAKAIGHR IRVMLYPSRI

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RPL35A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.35
Highest tissue expression
2,292 nTPM

Expression across tissuesHPA

Tissue

  • ovary: 2,292 nTPM
  • pancreas: 1,689 nTPM
  • skin: 1,236 nTPM
  • cervix: 1,192 nTPM
  • breast: 1,139 nTPM
  • vagina: 1,103 nTPM

Single-cell type

  • decidual stromal cells: 7,060 nCPM
  • ovarian stromal cells: 6,974 nCPM
  • esophageal suprabasal cells: 5,918 nCPM
  • esophageal basal cells: 5,602 nCPM
  • breast secretory cells: 5,459 nCPM
  • extravillous trophoblasts: 5,381 nCPM

Immune cell

  • total PBMC: 2,094 nTPM
  • naive CD4 T-cell: 1,650 nTPM
  • memory CD4 T-cell: 1,279 nTPM
  • naive CD8 T-cell: 1,253 nTPM
  • memory B-cell: 1,227 nTPM
  • MAIT T-cell: 1,158 nTPM

Brain region

  • spinal cord: 205 nTPM
  • white matter: 202 nTPM
  • hypothalamus: 198 nTPM
  • thalamus: 194 nTPM
  • medulla oblongata: 178 nTPM
  • basal ganglia: 171 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about RPL35A.

Disease | AllUniProt

Conditions RPL35A is implicated in, by any mechanism.

Disease | GeneticClinVar

13 pathogenic / likely-pathogenic of 144 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.41
gnomAD pLI
0.9
gnomAD missense Z
1.37
DepMap mean gene effect
-1.56
DepMap dependency class
pan

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of RPL35A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RPL35A as an antibody target. Whether an autoantibody or antibody against RPL35A could matter depends on whether native RPL35A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RPL35A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RPL35A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RPL35A. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...